cellulose acetate phthalate , CAP (skrót)

An alkaline bath softens the cellulose acetate phthalate binder.

Conclusions Cellulose acetate phthalate (CAP) is a pharmaceutical excipient which has been used for over four decades for enteric film coating of tablets and capsules.

Phthalic anhydride reacted with cellulose acetate forms cellulose acetate phthalate (CAP), a common enteric coating excipient that has also been shown to have antiviral activity.

Screening of pharmaceutical excipients revealed that cellulose acetate phthalate (CAP), commonly used for enteric coating of tablets and capsules [ 1 ] , has anti-HIV-1 activity.

The most common way to prepare cellulose acetate phthalate consists of the reaction of a partially substituted cellulose acetate (CA) with phthalic anhydride in the presence of an organic solvent and a basic catalyst.

Background Cellulose acetate phthalate (CAP) is a promising microbicide candidate for prevention of infection by sexually transmitted disease (STD) pathogens, including HIV-1 [ 1 2 3 4 5 6 7 ] .

Cellulose acetate phthalate (CAP), also known as cellacefate and cellulosi acetas phthalas, is a commonly used polymer phthalate in the formulation of pharmaceuticals, such as the enteric coating of tablets or capsules and for controlled release formulations.

Cellulose acetate phthalate is commonly plasticized with diethyl phthalate, a hydrophobic compound, or triethyl citrate, a hydrophilic compound; other compatible plasticizers are various phthalates, triacetin, dibutyl tartrate, glycerol, propylene glycol, tripropionin, triacetin citrate, acetylated monoglycerides, etc.